Recommendations

ACC - www.acc.org
AHA - www.americanheart.org
SCAI - www.scai.org
Smith et al. 2005
ACC/AHA/SCAI Practice Guidelines
99
197. Tcheng JE, Kereiakes DJ, Braden GA, et al. Safety of abciximab
retreatment: final clinical report of the ReoPro readministration
registry (R3). Circulation 1998;98 (Suppl):I-17.
198. Randomised placebo-controlled trial of effect of eptifibatide on
complications of percutaneous coronary intervention: IMPACT-
II. Integrilin to Minimise Platelet Aggregation and Coronary
Thrombosis-II. Lancet 1997;349:1422-8.
199. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in
patients with acute coronary syndromes. The PURSUIT Trial
Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Angina:
Receptor Suppression Using Integrilin Therapy. N Engl J Med
1998;339:436-43.
200. Novel dosing regimen of eptifibatide in planned coronary stent
implantation (ESPRIT): a randomised, placebo-controlled trial.
Lancet 2000;356:2037-44.
201. O’shea JC, Madan M, Cantor WJ, et al. Design and methodology
of the ESPRIT trial: evaluating a novel dosing regimen eptifibatide
in percutaneous coronary intervention. Am Heart J
2000;140:834-9.
202. Dery JP, Braden GA, Lincoff AM, et al. Final results of the
ReoPro readministration registry. Am J Cardiol 2004;93:979-84.
203. Ardissino D, Cavallini C, Bramucci E, et al. Sirolimus-eluting vs
uncoated stents for prevention of restenosis in small coronary
arteries: a randomized trial. JAMA 2004;292:2727-34.
204. Watanabe CT, Maynard C, Ritchie JL. Comparison of short-term
outcomes following coronary artery stenting in men versus
women. Am J Cardiol 2001;88:848-52.
205. Bavry AA, Kumbhani DJ, Quiroz R, Ramchandani SR, Kenchaiah
S, Antman EM. Invasive therapy along with glycoprotein IIb/IIIa
inhibitors and intracoronary stents improves survival in non-STsegment
elevation acute coronary syndromes: a meta-analysis and
review of the literature. Am J Cardiol 2004;93:830-5.
206. Wiviott SD, Cannon CP, Morrow DA, et al. Differential expression
of cardiac biomarkers by gender in patients with unstable
angina/non-ST-elevation myocardial infarction: a TACTICS-TIMI
18 (Treat Angina with Aggrastat and determine Cost of Therapy
with an Invasive or Conservative Strategy-Thrombolysis In
Myocardial Infarction 18) substudy. Circulation 2004;109:580-6.
207. Tamis-Holland JE, Palazzo A, Stebbins AL, et al. Benefits of direct
angioplasty for women and men with acute myocardial infarction:
results of the Global Use of Strategies to Open Occluded Arteries
in Acute Coronary Syndromes Angioplasty (GUSTO II-B)
Angioplasty Substudy. Am Heart J 2004;147:133-9.
208. Wong SC, Sleeper LA, Monrad ES, et al. Absence of gender differences
in clinical outcomes in patients with cardiogenic shock
complicating acute myocardial infarction. A report from the
SHOCK Trial Registry. J Am Coll Cardiol 2001;38:1395-401.
209. Movsowitz HD, Emmi RP, Manginas A, et al. Directional coronary
atherectomy in women compared with men. Clin Cardiol
1994;17:597-602.
210. Ahmed JM, Dangas G, Lansky AJ, et al. Influence of gender on
early and one-year clinical outcomes after saphenous vein graft
stenting. Am J Cardiol 2001;87:401-5.
211. Thompson RC, Holmes DR Jr, Gersh BJ, Mock MB, Bailey KR.
Percutaneous transluminal coronary angioplasty in the elderly:
early and long-term results. J Am Coll Cardiol 1991;17:1245-50.
212. Wennberg DE, Makenka DJ, Sengupta A, et al. Percutaneous
transluminal coronary angioplasty in the elderly: epidemiology,
clinical risk factors, and in-hospital outcomes. The Northern New
England Cardiovascular Disease Study Group. Am Heart J
1999;137:639-45.
213. Iakovou I, Dangas G, Mintz GS, et al. Comparison of frequency
of hemorrhagic stroke in patients or =75 years
of age among patients receiving glycoprotein IIb/IIIa inhibitors
during percutaneous coronary interventions. Am J Cardiol
2004;93:346-9.
214. Assali AR, Moustapha A, Sdringola S, et al. The dilemma of success:
percutaneous coronary interventions in patients > or = 75
years of age-successful but associated with higher vascular complications
and cardiac mortality. Catheter Cardiovasc Interv
2003;59:195-9.
215. Taddei CF, Weintraub WS, Douglas JS Jr, et al. Influence of age
on outcome after percutaneous transluminal coronary angioplasty.
Am J Cardiol 1999;84:245-51.
216. Tsai TP, Chaux A, Kass RM, Gray RJ, Matloff JM. Aortocoronary
bypass surgery in septuagenarians and octogenarians. Cardiovasc
Surg (Torino) 1989;30:364-8.
217. Holt GW, Sugrue DD, Bresnahan JF, et al. Results of percutaneous
transluminal coronary angioplasty for unstable angina pectoris
in patients 70 years of age and older. Am J Cardiol 1988;61:
994-7.
218. Cohen HA, Williams DO, Holmes DR, Jr., et al. Impact of age on
procedural and 1-year outcome in percutaneous transluminal
coronary angioplasty: a report from the NHLBI Dynamic
Registry. Am Heart J 2003;146:513-9.
219. Simpfendorfer C, Raymond R, Schraider J, et al. Early- and longterm
results of pecutaneous transluminal coronary angioplasty in
patients 70 years of age and older with angina pectoris. Am J
Cardiol 1988;62:959-61.
220. Klein LW, Block P, Brindis RG, et al. Percutaneous coronary
interventions in octogenarians in the American College of
Cardiology-National Cardiovascular Data Registry: development
of a nomogram predictive of in-hospital mortality. J Am Coll
Cardiol 2002;40:394-402.
221. Chauhan MS, Kuntz RE, Ho KL, et al. Coronary artery stenting
in the aged. J Am Coll Cardiol 2001;37:856-62.
222. Bach RG, Cannon CP, Weintraub WS, et al. The effect of routine,
early invasive management on outcome for elderly patients with
non-ST-segment elevation acute coronary syndromes. Ann Intern
Med 2004;141:186-95.
223. Guagliumi G, Stone GW, Cox DA, et al. Outcome in elderly
patients undergoing primary coronary intervention for acute
myocardial infarction: results from the Controlled Abciximab and
Device Investigation to Lower Late Angioplasty Complications
(CADILLAC) trial. Circulation 2004;110:1598-604.
224. Trial of invasive versus medical therapy in elderly patients with
chronic symptomatic coronary-artery disease (TIME): a randomised
trial. Lancet 2001;358:951-7.
225. Batchelor WB, Anstrom KJ, Muhlbaier LH, et al. Contemporary
outcome trends in the elderly undergoing percutaneous coronary
interventions: results in 7,472 octogenarians. National
Cardiovascular Network Collaboration. J Am Coll Cardiol
2000;36:723-30.
226. Terrin ML, Williams DO, Kleiman NS, et al. Two- and three-year
results of the Thrombolysis in Myocardial Infarction (TIMI)
Phase II clinical trial. J Am Coll Cardiol 1993;22:1763-72.
227. Aguirre FV, Younis LT, Chaitman BR, et al. Early and 1-year clinical
outcome of patients’ evolving non-Q-wave versus Q-wave
myocardial infarction after thrombolysis: results from the TIMI
II Study. Circulation 1995;91:2541-8.
228. Laskey WK, Selzer F, Vlachos HA, et al. Comparison of in-hospital
and one-year outcomes in patients with and without diabetes
mellitus undergoing percutaneous catheter intervention (from the
National Heart, Lung, and Blood Institute Dynamic Registry). Am